DE NOVO HYPOXEMIC ACUTE RESPIRATORY FAILURE (HARF)

Clinical trials for DE NOVO HYPOXEMIC ACUTE RESPIRATORY FAILURE (HARF) explained in plain language.

Never miss a new study

Get alerted when new DE NOVO HYPOXEMIC ACUTE RESPIRATORY FAILURE (HARF) trials appear

Sign up with your email to follow new studies for DE NOVO HYPOXEMIC ACUTE RESPIRATORY FAILURE (HARF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy could slash deaths in severe breathing failure

Disease control Recruiting now

This study tests whether adding continuous positive airway pressure (CPAP) to high-flow nasal cannula (HFNC) oxygen therapy reduces deaths in patients with severe, sudden breathing failure. About 1,084 adults in intensive care will be randomly assigned to receive either HFNC alon…

Matched conditions: DE NOVO HYPOXEMIC ACUTE RESPIRATORY FAILURE (HARF)

Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Apr 30, 2026 15:52 UTC

DE NOVO HYPOXEMIC ACUTE RESPIRATORY FAILURE (HARF)

Get alerted when new DE NOVO HYPOXEMIC ACUTE RESPIRATORY FAILURE (HARF) trials appear

New combo therapy could slash deaths in severe breathing failure